Jingsheng Capital
VC Fund
Shenzhen, China
Jingsheng Capital is an investment firm that offers investment management service.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 56%
Last updated:
For AI agents: llms.txt
Industries Jingsheng Capital invests in
Stages Jingsheng Capital invests in
Countries Jingsheng Capital invests in
Round sizes
Round size
- Seed
- $2.1M–$14M
- Angel
- $7.1M–$7.3M
Investment Focus
Industry
- Medical 3 (33%)
- Biotechnology 3 (33%)
- Internet 2 (22%)
- Food and Beverage 2 (22%)
- FinTech 1 (11%)
Stage
- Seed 3 (33%)
- Angel 3 (33%)
- Series A 1 (11%)
- Series B 1 (11%)
- Series C 1 (11%)
Country
- China 6 (67%)
- United States 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Shengtai Biosciences
|
Shengtai Bio uses photochemiluminescence as its core to develop POCT platforms, including chip-based molecular systems for fast diagnostics. | Series A / Oct 17, 2025 | |
Weimai Medical
|
Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions. | $99M / Series B / Feb 17, 2025 | |
|
Hanbuxiang
|
Hanbuxiang is a non-legacy Korean food brand. The company preserves the genuine Korean delights while incorporating current dietary concepts for innovation and enhancement. | Seed / Oct 16, 2024 | |
|
Hanbu Lane
|
Hanbu Lane is an intangible cultural heritage Korean food brand. On the basis of maintaining the authentic Korean delicacies, the company integrates modern food concepts for innovation and improvement, forming a unique Korean food practice system. | Angel / Oct 12, 2024 | |
Enokiko
|
Enokiko is a provider of synthetic biology platforms oriented to the study, creation, and manufacturing of environmentally friendly biological products. | $13.7M / Seed / Nov 03, 2023 | |
Enochic
|
Enochic is a synthetic biology platform provider. | $7.1M / Angel / Jan 05, 2023 | |
|
Enokiko
|
Enokiko is a provider of synthetic biology platforms oriented to the study, creation, and manufacturing of environmentally friendly biological products. | $7.3M / Angel / Jan 05, 2023 | |
BaishanCloud
|
Founded in April 2015, BaishanCloud (BSC) is a provider of cloud-managed services, specializing in cloud resource exchanges and interactions. With a strong emphasis on data governance, BSC’s cloud-managed product suite comprises three major services – cloud delivery, cloud storage, and cloud linkages. EdgeNext was the first company to introduce theCCX concept– Cloud Connects Everything – to the China market. Leveraging its robust and loosely coupled cloud delivery and cloud storage network, BaishanCloud provides a cloud management platform to fulfill enterprise customers' data migration and data integration needs. The platform provides data storage, integration, acceleration, and analytics services. | $37.4M / Series C / May 31, 2018 | |
Wangtouwang.com
|
Wangtouwang.com is a P2P financial management platform. | $2.1M / Seed / Sep 23, 2016 |
Co-Investors
Huaige Capital
2 deals together
FC Capital
1 deal together
Furong Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Jingsheng Capital invest in?
Jingsheng Capital invests primarily in Medical, Biotechnology and Internet startups, most often at Seed and Angel stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Jingsheng Capital's check size?
Jingsheng Capital typically joins rounds of $2.1M–$14M at Seed and $7.1M–$7.3M at Angel. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Jingsheng Capital participates in.
When did Jingsheng Capital last invest?
The most recent investment recorded for Jingsheng Capital closed in Oct 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
